Emvision Medical Devices Ltd has released a press release.
Clinical Trial Data Drives Confidence for Expanded Studies
Filed with ASX ·
6ix hasn’t read this filing yet.
EMvision Medical Devices Ltd. on 6ix
Earlier from EMvision Medical Devices
- AGM Chairmans Address & Presentation
- AGM Chairman's Address & Presentation
- FDA Breakthrough Device Application Update
- ASA & EMVision Sign $8m Project Agreement
- Appendix 4E & Annual Report 30 June 2021
Later from EMvision Medical Devices
- Notification regarding unquoted securities - EMV
- EMVision Receives $3.4m Non-Dilutive Funding this Quarter
- EMV Technology to be Presented at Prestigious Conference
- Application for quotation of securities - EMV
- S&P DJI Announces March 2022 Quarterly Rebalance
Follow EMvision Medical Devices into a list and get an email when it puts out news.
Follow EMvision Medical Devices